Hormone therapy was found effective in reducing insulin resistance in menopausal women
A new meta-analysis presented at the 2024 Annual Meeting of The Menopause Society suggests that hormone therapy could significantly benefit menopausal women by reducing insulin resistance 
Multiple myeloma drug shows efficacy in treating rare bleeding disorder
A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder.
Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases
A genetic connection between cardiovascular disease and psoriasis highlights shared inflammatory pathways, emphasizing the need for cardiovascular monitoring.
Study links diabetes drugs to lower risk of dementia and Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.
Extended estrogen suppression treatment found safe for postmenopausal breast cancer patients
New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, a sign of active coronary atherosclerosis, as some prior studies had indicated.
Breast cancer drug Kisqali gets FDA approval to prevent cancer recurrence
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce the chances of a patient's breast cancer coming back by 25%.
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced Tuesday.
Three cups of black coffee a day enough to lower diabetes, heart disease risk
The study found that people who regularly drank coffee or consumed caffeine, especially in moderate amounts, had a lower risk of developing multiple cardiometabolic diseases, which refers to having at least two heart or metabolic conditions at the same time.
Coffee and caffeine intake linked to lower risk of cardiometabolic disease
New research suggests that regular coffee and moderate amounts of caffeine may be protective against developing multiple cardiometabolic diseases   
How does PCOS affect heart health? Know risk and prevention tips
Effective management of cardiovascular health in women with PCOS involves lifestyle changes, stress management, and regular monitoring. These measures can significantly reduce heart disease risk and improve overall well-being.
last updated on 19 Sep 18:36